Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The lysine‐specific methyltransferase KMT 2C/ MLL 3 regulates DNA repair components in cancer
Θεόδωρος Ράμπιας, Dimitris Karagiannis, Margaritis Avgeris, et al.
EMBO Reports (2019) Vol. 20, Iss. 3
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade
Robert J. Motzer, Romain Banchereau, Habib Hamidi, et al.
Cancer Cell (2020) Vol. 38, Iss. 6, pp. 803-817.e4
Open Access | Times Cited: 410
COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer
Richard Fagan, Andrew K. Dingwall
Cancer Letters (2019) Vol. 458, pp. 56-65
Open Access | Times Cited: 137
Targeting DNA repair in cancer: current state and novel approaches
Apostolos Klinakis, Dimitris Karagiannis, Θεόδωρος Ράμπιας
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 4, pp. 677-703
Closed Access | Times Cited: 81
Integration of comprehensive genomic profiling, tumor mutational burden, and PD‐L1 expression to identify novel biomarkers of immunotherapy in non‐small cell lung cancer
Yunfei Shi, Youming Lei, Li Liu, et al.
Cancer Medicine (2021) Vol. 10, Iss. 7, pp. 2216-2231
Open Access | Times Cited: 66
Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair
Akira Ooki, Hiroki Osumi, Koichiro Yoshino, et al.
Gastric Cancer (2024) Vol. 27, Iss. 5, pp. 907-931
Open Access | Times Cited: 12
Recruitment of KMT2C/MLL3 to DNA Damage Sites Mediates DNA Damage Responses and Regulates PARP Inhibitor Sensitivity in Cancer
Antao Chang, Liang Liu, Justin M. Ashby, et al.
Cancer Research (2021) Vol. 81, Iss. 12, pp. 3358-3373
Open Access | Times Cited: 55
Towards a more precise therapy in cancer: Exploring epigenetic complexity
Fernando P. Cossío, Manel Esteller, María Berdasco
Current Opinion in Chemical Biology (2020) Vol. 57, pp. 41-49
Open Access | Times Cited: 50
Association of KMT2C/D loss‐of‐function variants with response to immune checkpoint blockades in colorectal cancer
Ruiqi Liu, Yan-Ling Niu, Chao Liu, et al.
Cancer Science (2023) Vol. 114, Iss. 4, pp. 1229-1239
Open Access | Times Cited: 20
Targeting histone modifiers in bladder cancer therapy — preclinical and clinical evidence
Shiyu Zhang, Tianhai Lin, Xingyu Xiong, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 8, pp. 495-511
Closed Access | Times Cited: 7
Medulloblastoma genomics in the modern molecular era
Rahul Kumar, Anthony P. Y. Liu, Paul A. Northcott
Brain Pathology (2019) Vol. 30, Iss. 3, pp. 679-690
Open Access | Times Cited: 52
MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant Breast Cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway
Han‐Tsang Wu, Yi-En Liu, Kai‐Wen Hsu, et al.
The American Journal of Chinese Medicine (2020) Vol. 48, Iss. 05, pp. 1221-1241
Closed Access | Times Cited: 49
Resolving DNA Damage: Epigenetic Regulation of DNA Repair
Panagiotis Karakaidos, Dimitris Karagiannis, Θεόδωρος Ράμπιας
Molecules (2020) Vol. 25, Iss. 11, pp. 2496-2496
Open Access | Times Cited: 48
Direct comparison of size-dependent versus EpCAM-dependent CTC enrichment at the gene expression and DNA methylation level in head and neck squamous cell carcinoma
Martha Zavridou, Sofia Mastoraki, Αreti Strati, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 44
Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer
Jonathan Thomas, Guru Sonpavde
Cancers (2022) Vol. 14, Iss. 7, pp. 1795-1795
Open Access | Times Cited: 24
Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal cancer evolution and metastatic development
Daniel Sobral, Marta Martins, Shannon Kaplan, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 24
SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases
Yue Li, Xinhua Yang, Weijie Zhu, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Pathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes
Dmitrijs Rots, Sanaa Choufani, Víctor Faúndes, et al.
The American Journal of Human Genetics (2024) Vol. 111, Iss. 8, pp. 1626-1642
Closed Access | Times Cited: 5
Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
Víctor G. Martínez, Ester Munera-Maravilla, Alejandra Bernardini, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 36
SET1/MLL family of proteins: functions beyond histone methylation
Jeyapal Sugeedha, Jyoti Gautam, Shweta Tyagi
Epigenetics (2020) Vol. 16, Iss. 5, pp. 469-487
Open Access | Times Cited: 34
RBM6 splicing factor promotes homologous recombination repair of double-strand breaks and modulates sensitivity to chemotherapeutic drugs
Feras E. Machour, Enas R. Abu‐Zhayia, Samah W. Awwad, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 20, pp. 11708-11727
Open Access | Times Cited: 29
Histone H3K4 Methyltransferases as Targets for Drug-Resistant Cancers
Yang Liu, Mingli Jin, Kwang Won Jeong
Biology (2021) Vol. 10, Iss. 7, pp. 581-581
Open Access | Times Cited: 28
Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes?
Murat Kantarcıoğlu, Gülşen Yıldırım, Pınar Akpınar Oktar, et al.
The Turkish Journal of Gastroenterology (2022) Vol. 34, Iss. 2, pp. 161-169
Open Access | Times Cited: 19
Loss of Kmt2c in vivo leads to EMT, mitochondrial dysfunction and improved response to lapatinib in breast cancer
Nikiana Simigdala, Anna Chalari, Aimilia D. Sklirou, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 4
Open Access | Times Cited: 12
Secernin‐2 Stabilizes Histone Methyltransferase KMT2C to Suppress Progression and Confer Therapeutic Sensitivity to PARP Inhibition in Triple‐Negative Breast Cancer
Min‐Ying Huang, Jianhui Cai, Shao‐Ying Yang, et al.
Advanced Science (2025)
Open Access
Regulation of nucleotide excision repair by wild-type HRAS signaling in head and neck cancer
L. Hoxhallari, Konstantinos Katsikis, A. Makri, et al.
Cancer Gene Therapy (2025)
Open Access
Page 1 - Next Page

Scroll to top